Ok Google What Is RSV and Everything You Need to Know

RSV is a common virus that affects people of all ages, but it's most severe in young children and older adults.

RSV can cause a range of symptoms, from mild to severe, including runny nose, cough, and fever.

The virus is highly contagious and can spread quickly in crowded areas, such as daycare centers and hospitals.

Symptoms usually appear 4-6 days after exposure to the virus and can last for up to 2 weeks.

RSV, or Respiratory Syncytial Virus, is a highly contagious virus that affects people of all ages, but it's most severe in young children and older adults.

RSV is highly contagious and can spread quickly through the air when an infected person coughs or sneezes.

RSV is caused by a virus, specifically the respiratory syncytial virus. It's not caused by bacteria, which is good to know for those who are prone to bacterial infections.

Close contact with someone who has RSV is a surefire way to get infected. This can be a family member, friend, or even a coworker.

Coughing and sneezing release respiratory droplets into the air, which can contain the virus. This is why it's so important to cover your mouth and nose when you cough or sneeze.

Contaminated objects or surfaces can also spread the virus. Think about all the things we touch every day, like toys, countertops, and phones.

RSV can infect anyone, but some people are at a higher risk of severe infection, including premature babies, young infants, and older adults with heart or lung disease.

RSV season typically occurs from fall to the end of spring, making it a good idea to take precautions during this time if you're in a high-risk group.

Most babies will have been infected with RSV at least once by the time they're 2 years old, and they can be reinfected with the virus anytime throughout life.

Some groups are at a higher risk of severe RSV infection, including:

RSV can be life-threatening for certain high-risk adults, with up to 160,000 older adults hospitalized in the United States each year.

RSV symptoms can be mild or severe, and they often start about 2 to 5 days after contact with the virus.

Cough, runny or stuffy nose, sneezing, sore throat, headache, fatigue, fever, and not feeling hungry are all common symptoms. In babies or young kids, symptoms might look a little different, and they might seem fussy or irritable.

Symptoms in children can include runny nose, fever, cough, short periods without breathing, trouble eating, drinking, or swallowing, wheezing, and flaring of the nostrils or straining of the chest or stomach while breathing.

Here are some severe symptoms that require immediate attention:

RSV can be diagnosed with a nasal swab or wash, which is a painless test to look for the virus in fluid from the nose. Your doctor will also ask about your child's symptoms and health history, and may give your child a physical exam.

RSV symptoms can be quite varied, but they often start within 2 to 5 days after contact with the virus. The early phase of RSV in babies and young children is often mild, like a cold.

Cough is a common symptom of RSV, and it can be accompanied by trouble breathing. In young infants, you might notice pauses in breathing, which can be a concerning sign.

Runny or stuffy nose, sneezing, and sore throat are also common symptoms of RSV. Headache and fatigue can also occur, and some people may experience a fever.

In babies or young kids, RSV symptoms might look a little different. They might seem fussy or irritable, or they might not want to play as they usually would.

Here are some severe symptoms that require immediate attention:

These symptoms can be a sign of a severe respiratory disease, so it's essential to seek medical attention if you notice any of them.

A healthcare provider swabs your nose with a soft-tipped stick to test for RSV. They may get a chest X-ray to look for pneumonia and other complications.

There are several laboratory tests available for diagnosing RSV infection, including antigen testing, molecular testing, and viral culture.

Antigen testing involves the detection of RSV antigen fragments from a nasopharyngeal swab or aspirate. This can be done using a direct fluorescence assay (DFA) or a rapid antigen detection test (RADT).

Rapid antigen detection tests (RADT) are commonly used as point-of-care testing due to their ease of use and quick turnaround time. These include both enzyme immunosorbent assays (EIA) and chromatographic immunoassays (CIA).

A doctor will ask about your child's symptoms and health history, and may also ask about any recent illness in your family or other children in childcare or school. They will give your child a physical exam.

The doctor may also perform a nasal swab or wash, which is a painless test to look for the virus in fluid from the nose.

Here are some common identification techniques for RSV infection:

RSV can last a week or two. You might have a lingering cough for a while. Severe cases of RSV may last longer.

In some cases, the symptoms can be quite persistent, making it feel like the illness is dragging on. A lingering cough is a common symptom that can stick around for a bit.

RSV can be treated to help ease symptoms, but it's essential to prevent it in the first place.

RSV treatment depends on the child's symptoms, age, and health. Antibiotics aren't used to treat RSV, and treatment may include more fluids, oxygen, suctioning of mucus, bronchodilator medicines, tube feeding, mechanical ventilation, and antiviral medicine.

To prevent RSV in infants, maternal RSV vaccination at 32-36 weeks of pregnancy is recommended, as is infant immunization with an RSV monoclonal antibody for babies 8 months and younger born during or entering their first RSV season.

Babies and children at high risk for RSV infection may get a different monoclonal antibody medicine, which is given as a series of shots once a month during RSV season. This helps prevent the illness in premature babies and children with health problems.

To reduce the risk for RSV, the American Academy of Pediatrics recommends all babies, especially preterm babies:

Make sure household members wash their hands or use an alcohol-based hand cleaner before and after touching your baby, and don't allow people to smoke in your home or in your car.

Reinfection is a common occurrence with RSV, affecting an estimated 36% of individuals at least once during the winter season. This is because the virus interferes with the establishment of immunological memory, making it difficult for our bodies to remember how to fight it off.

RSV reinfection can happen throughout life, which is why we see winter/early spring epidemics in temperate regions. The synchronization of RSV activity can vary widely depending on the region you live in.

Unless you're immunocompromised, adult reinfections tend to have mild symptoms, usually restricting upper airways. This is because adults have a more established immune system that can handle the virus.

However, younger individuals are extremely vulnerable to developing severe symptoms, which typically involve the lower airways. Infants, with their smaller airways, are particularly at risk of developing a more severe lower respiratory tract illness due to inflammation, edema, and mucus obstruction.

The age at which you're infected with RSV can be a crucial factor in determining the phenotype of your airway response to subsequent RSV infection. This means that the type of host response to reinfection can determine which children will develop persistent wheezing and possibly asthma.

Preventing RSV in your child is crucial, especially during the first winter season. Maternal RSV vaccination at 32 through 36 weeks of pregnancy can help prevent severe RSV disease in infants.

The CDC recommends maternal RSV vaccination be given immediately before or during RSV season. This can be a lifesaver for your little one.

Infant immunization with an RSV monoclonal antibody for babies 8 months and younger born during or entering their first RSV season is also recommended. This can provide an extra layer of protection against RSV.

For babies and children at high risk for RSV infection, a different monoclonal antibody medicine may be advised. This is given as a series of shots once a month during RSV season.

To reduce the risk for RSV, follow these simple yet effective tips:

Remember, hand hygiene is key. Make sure household members wash their hands or use an alcohol-based hand cleaner before and after touching your baby.

RSV treatment is focused on easing symptoms, not curing the virus. Antibiotics won't work, so doctors will assess your child's symptoms, age, and health to determine the best course of action.

Treatment may include giving your child more fluids to drink, either by mouth or through an IV line if needed. This is crucial to prevent dehydration.

Oxygen therapy may be necessary to help your child breathe more easily. This can be done through a mask, nasal prongs, or an oxygen tent.

In some cases, suctioning mucus from the lungs may be necessary to help your child breathe better. This is done with a thin tube inserted into the lungs.

Bronchodilator medicines can be used to open up your child's airways, making it easier for them to breathe. These are often given in an aerosol mist through a mask or inhaler.

If your child has trouble sucking, tube feeding may be an option. This involves a thin tube inserted through the nose and down into the stomach to deliver liquid nutrition.

In severe cases, mechanical ventilation may be necessary to help your child breathe. This involves using a breathing machine, or ventilator, to assist with breathing.

Some children with severe infections may require antiviral medicine to help combat the infection.

Vaccines offer a promising solution to preventing RSV disease.

RSV infection is widespread in early childhood, contributing significantly to the global disease burden.

Vaccine development has faced obstacles, including the immature infant immune system and the presence of maternal antibodies, which make infantile immunization difficult.

Ongoing efforts focus on creating vaccines that confer durable protection, with field trials eagerly anticipated.

The first RSV vaccines, Arexvy and Abrysvo, were approved by the US FDA in May 2023.

Mresvia, an mRNA vaccine, was approved for medical use in the United States in May 2024.

Viral-specific therapies are being researched and developed to combat RSV infections. Ribavirin is an antiviral medication licensed for the treatment of RSV in children, but its use remains controversial due to unclear evidence of efficacy and concerns about toxicity.

It was approved in 1986 for treatment of RSV infection, but treatment guidelines do not make recommendations for its use in children. In adults, ribavirin is used off-label and is generally reserved for the severely immunocompromised.

Curious to learn more? Check out: Google Documents How to Use

Presatovir, an experimental antiviral drug, has shown promising results in clinical trials but has not yet been approved for medical use. It acts as a fusion inhibitor by inhibiting the RSV F protein.

Immunoglobins, both RSV-specific and non-specific, have historically been used for RSV-related illnesses, but there is insufficient evidence to support their use in children with RSV infection.

AstraZeneca and Sanofi introduced nirsevimab, a prophylactic monoclonal antibody with 75% efficacy against RSV cases in infants under one year. It was approved in Europe in November 2022 and in the US in July 2023.

Merck's clesrovimab, a similar monoclonal antibody, is in late-stage trials.

Broaden your view: How to Operate Google Drive

RSV can cause some serious complications, especially in high-risk groups.

Infants, especially those born prematurely or who are 6 months or younger, are at a higher risk of severe infection.

RSV can lead to severe breathing problems, pneumonia, and even life-threatening conditions in these vulnerable populations.

Children with heart disease, weakened immune systems, or neuromuscular disorders are also more likely to experience complications.

Older adults, especially those 65 and older, are at increased risk of severe infection and complications.

Some possible complications of RSV include bronchitis, pneumonia, bronchiolitis, and worsening of existing conditions like asthma or COPD.

Here are some specific complications that can occur:

It's essential to note that RSV can cause complications that can be life-threatening, so if you or your child is experiencing symptoms, seek medical attention promptly.

RSV in children is a common viral illness that causes trouble breathing. Most babies have been infected at least once by the time they are 2 years old, and babies can also be reinfected with the virus.

RSV is a leading cause of bronchiolitis and pneumonia in infants and children under the age of 5. The risk of serious infection is highest during the first 6 months of life.

In high-risk babies, RSV can lead to severe breathing problems and pneumonia. It may become life-threatening. Having RSV as a baby may be linked to having asthma later in childhood.

Babies born prematurely or with heart, lung, or immune system diseases are at increased risk for more severe illness. Children with asthma are also at higher risk for dangerous breathing problems.

RSV season is the fall to the end of spring, when outbreaks tend to occur. Children who attend child care centers or who have siblings who attend school are at a higher risk of exposure and reinfection.

Here are some groups at higher risk for severe RSV infections:

RSV is a common virus that you've likely had before, but might not have known was RSV.

You don't develop complete immunity to RSV, which means you can get it multiple times, even in the same year.

RSV has the potential to make you really sick, and in some cases, it can be severe enough to require hospitalization.

Up to 10,000 older adults die of complications from RSV each year in the United States.

Typically, as an adult, RSV symptoms are mild and cold-like, such as a runny nose, sore throat, cough, and headache.

RSV and COVID-19 are both types of respiratory viruses, which means some symptoms can be similar.

In children, COVID-19 often results in mild symptoms such as fever, runny nose, and cough.

Having RSV may lower immunity and increase the risk of getting COVID-19 for kids and adults.

An infected person is most contagious during the first week or so after infection.

For infants and those with weakened immunity, the virus may continue to spread even after symptoms go away, for up to four weeks.

If you have symptoms of a respiratory illness, your doctor may recommend testing for COVID-19.

COVID-19 symptoms in adults can be more severe and may include trouble breathing.

If you or your child has severe RSV symptoms, go to the emergency room right away. Severe symptoms include signs of difficulty breathing, such as wheezing, flaring nostrils, chest retractions, or bluish or grayish skin color.